Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ijivanjee
    Junior Member
    • Jun 2011
    • 8

    #1

    Reactions vs. Samples

    I'm sorry, this is a dumb question.

    When a company advertises 96 reactions, does that essentially mean the product can handle 96 samples? I'm speaking in context of target enrichment/DNA capture.
    www.idtdna.com
    [email protected]
  • GW_OK
    Senior Member
    • Sep 2009
    • 411

    #2
    I think it means you can capture something 96 times. You could do 1 sample 96 times or 96 samples 1 time. That's how I would read it.

    Comment

    • ijivanjee
      Junior Member
      • Jun 2011
      • 8

      #3
      So if a product offers 10 reactions with a max size of 2 MB, then I can have 10 samples with 1X coverage on 2 MB OR I can have 1 sample with 10X coverage on 2MB?
      www.idtdna.com
      [email protected]

      Comment

      • GW_OK
        Senior Member
        • Sep 2009
        • 411

        #4
        I don't think coverage comes into it. That's more of a sequencing issue, not capture.
        I would read "10 reactions with a max size of 2 MB" to mean you may capture up to 2MB total 10 times from any number of samples between 1 and 10.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          Today, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        68 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...